Na-Li countertransport kinetics in the relatives of hypertensive patients with abnormal Na-Li countertransport

P A Rutherford1, T H Thomas, R Wilkinson

  • 1Department of Medicine (Nephrology), University of Newcastle upon Tyne, Newcastle upon Tyne, United Kingdom.

Insights

Familial factors significantly influence sodium-lithium countertransport kinetics, specifically the Michaelis constant (Km) and Vmax/Km ratio, in essential hypertension. These genetic influences are crucial for understanding the inheritance of hypertension.

Area of Science:

  • Cardiovascular Physiology
  • Human Genetics
  • Biochemistry

Background:

  • Essential hypertension exhibits high sodium-lithium countertransport activity, influenced by both familial and environmental factors.
  • This activity is characterized by a low Michaelis constant (Km) and high Vmax/Km ratio, while Vmax is affected by dyslipidemia.

Purpose of the Study:

  • To investigate the influence of familial factors on the Michaelis constant (Km) and Vmax/Km ratio of sodium-lithium countertransport activity.
  • To determine if genetic predisposition affects the kinetic determinants of sodium-lithium countertransport in essential hypertension.

Main Methods:

  • Measured sodium-lithium countertransport kinetics (Na-stimulated Li efflux from erythrocytes) in first-degree relatives of hypertensive probands and normotensive controls.
  • Analyzed kinetic parameters including Michaelis constant (Km) and Vmax/Km ratio.

Main Results:

  • Relatives exhibited significantly reduced Km and increased Vmax/Km compared to controls.
  • A subset of relatives displayed high sodium-lithium countertransport activity, characterized by low Km and high Vmax/Km.
  • Hypertensive relatives showed abnormalities in sodium-lithium countertransport kinetics.

Conclusions:

  • Familial factors play a significant role in determining the Km and Vmax/Km of sodium-lithium countertransport activity.
  • Accurate assessment of sodium-lithium countertransport inheritance requires measurement of its kinetic determinants to avoid confounding variables.

Related Concept Videos

Antihypertensive Drugs: Action of Diuretics01:16

Antihypertensive Drugs: Action of Diuretics

Diuretics are antihypertensive drugs used to treat hypertension resulting from sodium and water retention. Sodium, vital for fluid balance and nerve or muscle function, is regulated by the kidneys through millions of nephrons. Blood enters nephrons via afferent arterioles, which branch into capillaries called glomeruli. These filter blood plasma, allowing water and solutes, like sodium ions, to pass through capillary walls into Bowman's capsule. The filtrate then flows through various tubules...
Antihypertensive Drugs: Potassium-Sparing Diuretics01:28

Antihypertensive Drugs: Potassium-Sparing Diuretics

Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Active Transport01:14

Active Transport

Active transport is a critical biological process that allows cells to move solutes against an electrochemical gradient. This process requires direct energy input and is characterized by its selectivity, saturability, and susceptibility to competitive inhibition.
Primary active transporters, like Na+, K+ and -ATPase, directly utilize ATP to move ions across the membrane. These transporters play significant roles in various physiological processes. For instance, Na+, K+ and -ATPase maintain...
Nonlinear Pharmacokinetics: Role of Transporters01:27

Nonlinear Pharmacokinetics: Role of Transporters

A drug's nonlinear kinetics can be influenced by a diverse range of transporter proteins that serve as crucial players in drug distribution. These transporters, found within cells, can enhance or reduce local drug concentrations by facilitating the influx or efflux of drugs. For instance, the expression of xenobiotic transporters can be influenced by factors such as age and gender, potentially impacting the linearity of drug response.
Polymorphisms occurring in drug transporters can alter...